One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: yes
Payment Terms: L/C
Disulfiram
No risk of nitrosoamine presence
All intermediates produced in-hous
Status
Commercial
Therapeutic cat.
Other
Polymorphic form
Substance does not show polymorphism
CAS No.
97-77-8
EU DMF readiness
CEP
Drug description
Disulfiram may be used to treat alcohol use disorder (also called chronic alcoholism) and works by blocking an enzyme that is involved in breaking down alcohol. Combining disulfiram with alcohol produces very unpleasant side effects which can help keep you from drinking. Disulfiram is not a cure for alcohol use disorder and other non-drug treatments, such as behavior modification, psychotherapy, and counseling support are needed in addition to disulfiram to give you the best possible chance to stop drinking. Disulfiram was FDA approved in 1951.
Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).